The Journal of clinical psychiatry
Journal
Overview
publication venue for
-
Body dysmorphic disorder: diagnosis and treatment of imagined ugliness.
1996
-
A Case of Semaglutide-Induced Euphoria in a Patient With Bipolar Disorder..
86.
2025
-
A Pilot Study of High-Frequency Transcranial Magnetic Stimulation for Bipolar Depression..
85.
2024
-
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies in the United States..
84.
2023
-
Prevalence and Correlates of Prescription Stimulant Misuse Among US College Students: Results From a National Survey..
84.
2022
-
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression: A Decade of Clinical Follow-Up..
82.
2021
-
Inaccurate Prescribing Warnings in Electronic Medical Record Systems: Results From an American Society of Clinical Psychopharmacology Membership Survey..
80.
2018
-
Twelve-Month Outcomes Following Successful Panic-Focused Psychodynamic Psychotherapy, Cognitive-Behavioral Therapy, or Applied Relaxation Training for Panic Disorder..
79.
2018
-
Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients..
79.
2018
-
Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder..
78.
2017
-
Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care Setting..
77.
2016
-
The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled Trial..
77.
2016
-
Psychotherapies for Panic Disorder: A Tale of Two Sites..
77.
2016
-
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study..
77.
2016
-
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder..
77.
2016
-
Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia..
76.
2015
-
Positive psychiatry: its time has come..
76.
2015
-
Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for Psychotic Depression (STOP-PD study)..
76.
2015
-
A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures..
74.
2013
-
The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression..
74.
2013
-
A controlled clinical treatment trial of interpersonal psychotherapy for depressed pregnant women at 3 New York City sites..
74.
2013
-
Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder..
73.
2012
-
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state..
73.
2011
-
Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group..
72.
2011
-
Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year..
72.
2011
-
Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?.
72.
2011
-
Antidepressant use in elderly suicide victims in New York city: an analysis of 255 cases..
70.
2009
-
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination..
70.
2009
-
Missed diagnosis of psychotic depression at 4 academic medical centers..
69.
2008
-
Virtual reality exposure therapy for the treatment of posttraumatic stress disorder following September 11, 2001..
68.
2007
-
Antidepressants in adult suicides in New York City: 2001-2004..
68.
2007
-
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases..
68.
2007
-
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study..
68.
2007
-
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study..
68.
2007
-
Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features..
68.
2007
-
Pilot randomized controlled trial of interpersonal counseling for subsyndromal depression following miscarriage..
67.
2006
-
Suicidal ideation and suicide attempts in body dysmorphic disorder..
66.
2005
-
Substance use disorders in individuals with body dysmorphic disorder..
66.
2005
-
Modafinil treatment for fatigue in HIV+ patients: a pilot study..
65.
2004
-
Alcohol use disorder comorbidity in eating disorders: a multicenter study..
65.
2004
-
Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998..
65.
2004
-
Childhood maltreatment as a risk factor for adult cardiovascular disease and depression..
65.
2004
-
An open-label study of citalopram in body dysmorphic disorder..
64.
2003
-
Venlafaxine in treatment-resistant obsessive-compulsive disorder..
64.
2003
-
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression..
63.
2002
-
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study..
62.
2001
-
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder..
62.
2001
-
A history of substance abuse complicates remission from acute mania in bipolar disorder..
60.
1999
-
Antidepressant treatment of depression in HIV-seropositive women..
60.
1999
-
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine..
59.
1998
-
A comparison study of body dysmorphic disorder and obsessive-compulsive disorder..
59.
1998
-
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies..
59.
1998
-
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine..
59.
1998
-
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine..
59.
1998
-
A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief..
59.
1998
-
Efficacy and safety of fluvoxamine in body dysmorphic disorder..
59.
1998
-
Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients..
59.
1998
-
Memory functioning in Lyme borreliosis..
57.
1996
-
Trichotillomania and self-esteem: a survey of 62 female hair pullers..
57.
1996
-
Medication use during psychoanalysis: a survey..
56.
1995
-
Body dysmorphic disorder: does it have a psychotic subtype?.
54.
1993
-
Long-term follow-up of chronic depression treated with imipramine..
52.
1991
-
Elevated blood neutrophil concentration in mania..
47.
1986
-
Discussion of "controversies in psychiatry": depression in the medically ill, sleep disorders in the elderly, and the DST..
46.
1985
-
Late-onset delusional depression: a distinct clinical entity?.
45.
1984
-
Diagnosis and treatment of depression in the cancer patient..
45.
1984
-
Affective and character pathology of suicidal adolescent and young adult inpatients..
45.
1984
-
Controversies in antidepressant therapy..
44.
1983
-
Mania scale scores, signs, and symptoms in forty inpatients..
44.
1983
-
Central noradrenergic neurons: identification, distribution and synaptic interactions with axons containing morphine-like peptides..
43.
1982
-
Clonidine: basic and clinical perspectives..
43.
1982
-
Catecholamine measures for diagnosis and treatment of patients with depressive disorders..
41.
1980
-
A star-struck service: impact of the admission of a celebrity to an inpatient unit..
39.
1978
-
Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology..
39.
1978
-
Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder..
79.
2018
-
Antidepressant augmentation: good news, limitations, and stumbling blocks..
76.
2015
-
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder..
73.
2012
-
Low-dose lithium augmentation of divalproex in geriatric mania..
61.
2000
-
Methylphenidate and SSRI-Induced sexual side effects..
57.
1996
-
Dr McClintock and Colleagues Reply.
2018
-
Dr McClintock and Colleagues Reply.
2018
-
Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects.
2014
-
Dr Gibbons and colleagues reply.
2014
-
Does depressive state influence reported attachment status?
2009
-
Agitated depression, panic anxiety, and clonazepam.
2006
-
Fatal body dysmorphic disorder by proxy.
2001
-
Muscle dysmorphia.
1997
-
Pimozide in clinical psychiatry.
1991
-
Using antipsychotic agents in older patients.
2004
-
Psychotherapy for late-life depression.
2010
-
Safety and tolerability of antidepressants: weighing the impact on treatment decisions.
2007
-
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.
2006
-
Employing pharmacologic treatment of bipolar disorder to greatest effect.
2004
-
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
2003
-
New approaches to managing psychotic depression.
2003
-
Role of executive function in late-life depression.
2003
-
Clinical use of nefazodone in major depression: a 6-year perspective.
2002
-
Clinical efficacy of reboxetine in major depression.
2000
-
New indications for antidepressants.
2000
-
New strategies for treating chronic depression.
2000
-
Antidepressant effectiveness in severe depression and melancholia.
1999
-
Bipolar disorder: recent issues in diagnosis and classification.
1998
-
Geriatric dysthymia.
1998
-
Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
1998
-
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
1997
-
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
1997
-
Geriatric psychiatry: an update.
1990
-
Weight gain in the treatment of mood disorders.
2003
-
Epidemiology, morbidity, and treatment of overweight and obesity.
2001
-
Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both?
1995
-
Kleptomania, compulsive buying, and binge-eating disorder.
1995
-
Obsessive compulsive spectrum disorder.
1994
-
The assessment and treatment of refractory depression.
1994
-
Depression and the cancer patient.
1990
-
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.
2018
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)